GO:0015718 monocarboxylic acid transport: Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015718 monocarboxylic acid transport describes the directed movement of monocarboxylic acids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore.
• The proton-coupled monocarboxylate transporters MCT1 (SLC16A1) and MCT4 (SLC16A3) are central to lactate, pyruvate, and ketone body transport across the plasma membrane.
• Monocarboxylic acid transport supports metabolic cooperation between cells, including oligodendroglial lactate supply to axons and tumor metabolic symbiosis.
• MCT1 and MCT4 also transport thyroid hormone derivatives and itaconate, linking this GO term to endocrine signaling and macrophage antibacterial immunity.
• Dual inhibition of MCT1 and MCT4 is synthetic lethal with metformin in cancer cells due to NAD+ depletion, making this pathway a therapeutic target.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of monocarboxylic acid transporter genes in disease and metabolism.
Description
Monocarboxylic acid transport (GO:0015718) is a biological process defined by the directed movement of monocarboxylic acids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Monocarboxylic acids include lactate, pyruvate, ketone bodies, and short-chain fatty acids, all of which are central to cellular energy metabolism and signaling. The process is mediated by dedicated transport proteins, most prominently the proton-coupled monocarboxylate transporters MCT1 (SLC16A1) and MCT4 (SLC16A3), which facilitate the rapid flux of these metabolites across membranes. Researchers study GO:0015718 because it connects metabolic state to cell fate, immune function, and disease. For example, oligodendroglia metabolically support axons through lactate transport, and disruption of this process contributes to neurodegeneration. In cancer, lactate transporters sustain tumor growth and metabolic symbiosis, and their inhibition can be synthetic lethal with metformin. Beyond lactate, MCT1 and MCT4 transport thyroid hormone derivatives and itaconate, expanding the biological roles of this GO term into endocrine regulation and host defense. Understanding the molecular players, regulation, and disease relevance of monocarboxylic acid transport is therefore essential for metabolic research, drug discovery, and the development of CRISPR-based cell models. This article integrates authoritative GO annotation with verified PubMed literature to provide a research-grade overview of GO:0015718.
monocarboxylic acid transport At A Glance
| GO ID | GO:0015718 |
|---|---|
| GO term | monocarboxylic acid transport |
| Ontology | biological_process |
| Synonym | none |
| Definition | The directed movement of monocarboxylic acids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| Major function | Transport of lactate, pyruvate, ketone bodies, and other monocarboxylic acids across membranes |
| Key transporters | MCT1 (SLC16A1), MCT4 (SLC16A3), and related SLC16 family members |
| Coupled mechanism | Proton-coupled symport for many MCT family members |
| Disease relevance | Cancer metabolism, neurodegeneration, thyroid hormone transport, and macrophage immunity |
What Is GO:0015718?
GO:0015718 monocarboxylic acid transport is the directed movement of monocarboxylic acids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. In practice, this process is carried out by membrane proteins that recognize monocarboxylic acids and move them across lipid bilayers, often coupled to proton gradients.
Why Is monocarboxylic acid transport Important in Cell Biology?
Monocarboxylic acid transport is important because it controls the availability of key metabolic fuels and signaling molecules such as lactate, pyruvate, and ketone bodies. This process enables metabolic cooperation between cells, supports neuronal function, and influences immune responses. Dysregulation of monocarboxylic acid transporters is implicated in cancer, neurodegeneration, and endocrine disorders, making GO:0015718 a high-value target for both basic research and therapeutic development.
• Maintains cellular energy homeostasis by moving lactate, pyruvate, and ketone bodies across membranes.
• Supports oligodendroglial metabolic support of axons, with implications for neurodegeneration.
• Enables tumor metabolic symbiosis and is a target for synthetic lethal strategies with metformin.
• Mediates transport of thyroid hormone derivatives, linking metabolism to endocrine signaling.
• Facilitates itaconate transport in macrophages, modulating antibacterial activity.
• Influences drug absorption and pharmacokinetics, as shown for ferulic acid in intestinal models.
• Contributes to interactions between natural products and cardiovascular/diabetic drugs.
• Provides a mechanistic basis for CRISPR-based metabolic and disease modeling.
What Happens During monocarboxylic acid transport?
Substrate recognition and binding
In simple terms: The transporter first grabs the monocarboxylic acid it will carry.
Monocarboxylic acid transporters such as MCT1 and MCT4 recognize substrates including lactate, pyruvate, and ketone bodies. Binding occurs at a specific site within the transporter, and the proton-coupled nature of MCT1 and MCT4 means that substrate recognition is linked to proton binding. This step determines which monocarboxylic acids can be transported and sets the stage for translocation.
Translocation across the membrane
In simple terms: The transporter then moves the acid from one side of the membrane to the other.
After binding, the transporter undergoes conformational changes that move the monocarboxylic acid across the lipid bilayer. For MCT1 and MCT4, this is a proton-coupled symport process, meaning the substrate and a proton are transported together. This translocation is the core event of GO:0015718 and can occur in either direction depending on the concentration and proton gradients.
Substrate release and gradient maintenance
In simple terms: The acid is released on the other side, and the cell keeps the gradient going.
Once translocation is complete, the monocarboxylic acid is released into the cytoplasm or extracellular space. Continued transport depends on maintaining appropriate concentration and pH gradients, which are influenced by cellular metabolism and the activity of other transporters. This release step ensures that lactate, pyruvate, and ketone bodies are delivered where they are needed for energy production or signaling.
Metabolic coupling and intercellular shuttling
In simple terms: Different cells can share these acids to support each other's metabolism.
Monocarboxylic acid transport enables metabolic coupling between cells. For example, oligodendroglia provide lactate to axons to support neuronal function, and disruption of this process contributes to neurodegeneration. In tumors, lactate shuttling between hypoxic and oxidative cells supports growth, and dual inhibition of MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion. These examples illustrate how GO:0015718 integrates with broader metabolic networks.
Transport of non-classical substrates
In simple terms: These transporters also carry other important molecules beyond lactate.
MCT1 and MCT4 transport thyroid hormone derivatives, linking monocarboxylic acid transport to endocrine regulation. They also mediate itaconate transport across the plasma membrane and Salmonella-containing vacuoles, modulating macrophage antibacterial activity. Additionally, monocarboxylic acid transporters facilitate the transepithelial transport of compounds such as ferulic acid in intestinal models, and can influence drug interactions.
Key Genes Involved in GO:0015718 monocarboxylic acid transport
The following genes and proteins are central to monocarboxylic acid transport (GO:0015718), based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC16A1 (MCT1) | Proton-coupled transporter for lactate, pyruvate, and ketone bodies | Cancer metabolism, drug transport, metabolic modeling |
| SLC16A3 (MCT4) | Proton-coupled transporter for lactate, especially in glycolytic cells | Tumor metabolic symbiosis, synthetic lethality with metformin |
| SLC16A2 (MCT8) | Transporter for thyroid hormone derivatives | Thyroid hormone transport and endocrine disorders |
| SLC16A10 (MCT10) | Transporter for aromatic amino acids and thyroid hormone derivatives | Thyroid hormone transport |
| SLC16A7 (MCT2) | High-affinity lactate and pyruvate transporter | Neuronal metabolism and metabolic coupling |
| SLC16A6 (MCT7) | Monocarboxylate transporter for ketone bodies and other substrates | Metabolic research |
| SLC16A8 (MCT3) | Retinal pigment epithelium-specific lactate transporter | Retinal metabolism |
| SLC16A4 (MCT5) | Orphan monocarboxylate transporter | Less characterized, potential metabolic roles |
| SLC16A5 (MCT6) | Monocarboxylate transporter with broad substrate specificity | Drug transport and pharmacokinetics |
| SLC16A9 (MCT9) | Monocarboxylate transporter associated with urate transport | Metabolic and renal research |
| SLC16A11 | Monocarboxylate transporter linked to lipid metabolism | Type 2 diabetes and metabolic disease |
| SLC16A13 | Monocarboxylate transporter with poorly defined substrates | Metabolic research |
| SLC16A14 | Monocarboxylate transporter expressed in brain and other tissues | Neurological and metabolic research |
| BSG (CD147) | Chaperone and accessory protein for MCT1 and MCT4 | Transporter trafficking and function |
| SLC2A1 (GLUT1) | Glucose transporter that indirectly supports lactate production | Metabolic coupling and cancer |
| LDHA | Lactate dehydrogenase A, produces lactate for transport | Cancer metabolism and metabolic modeling |
| LDHB | Lactate dehydrogenase B, consumes lactate after transport | Metabolic symbiosis and oxidative metabolism |
How Is monocarboxylic acid transport Regulated?
Monocarboxylic acid transport is regulated at multiple levels. MCT1 and MCT4 expression is influenced by metabolic state, hypoxia, and oncogenic signaling, and their trafficking to the plasma membrane depends on accessory proteins such as BSG (CD147). Transport activity is also regulated by substrate availability and proton gradients, which are tied to cellular metabolism. In cancer cells, dual inhibition of MCT1 and MCT4 combined with metformin leads to NAD+ depletion and synthetic lethality, indicating that transport regulation intersects with redox and energy stress pathways. Additionally, thyroid hormone derivative transport by MCT8 and MCT10 is subject to endocrine feedback and developmental regulation.
monocarboxylic acid transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC16A1 (MCT1) | Cancer metabolism, synthetic lethality with metformin | CRISPR knockout in cancer cell lines |
| SLC16A3 (MCT4) | Tumor metabolic symbiosis, hypoxia adaptation | Knockout and overexpression models |
| SLC16A2 (MCT8) | Thyroid hormone transport disorders | Point-mutation knock-in in neuronal cells |
| SLC16A10 (MCT10) | Thyroid hormone derivative transport | Knockout in endocrine cell models |
| MCT1/MCT4 | Macrophage antibacterial activity via itaconate transport | Knockout in macrophage cell lines |
Cancer metabolism and synthetic lethality
Monocarboxylic acid transporters, particularly MCT1 and MCT4, are critical for tumor metabolic symbiosis. Hypoxic tumor cells export lactate via MCT4, which is taken up by oxidative tumor cells via MCT1 to fuel respiration. Dual inhibition of MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion, highlighting the therapeutic potential of targeting GO:0015718 in cancer. These findings support the use of CRISPR models to dissect transporter dependencies in different tumor contexts.
Neurodegeneration and axonal support
Oligodendroglia metabolically support axons by providing lactate, a process dependent on monocarboxylic acid transport. Disruption of this support contributes to neurodegeneration, as shown in models where oligodendroglial metabolic function is impaired. This links GO:0015718 to diseases such as amyotrophic lateral sclerosis and other neurodegenerative conditions, and suggests that modulating lactate transport could be neuroprotective.
Thyroid hormone transport and endocrine disorders
MCT8 (SLC16A2) and MCT10 (SLC16A10) transport thyroid hormone derivatives, and mutations in these transporters cause endocrine and neurological disorders. The transport of 3,3',5-triiodothyroacetic acid by these transporters further expands the role of monocarboxylic acid transport in thyroid hormone biology. These findings make GO:0015718 relevant to endocrine research and pediatric neurology.
Macrophage immunity and itaconate transport
Itaconate, a monocarboxylic acid with antibacterial properties, is transported across the plasma membrane and Salmonella-containing vacuoles via MCT1 and MCT4. This transport modulates macrophage antibacterial activity, linking GO:0015718 to host defense and infectious disease. Understanding this process may inform strategies to enhance innate immunity.
From monocarboxylic acid transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MCT1 affect lactate uptake and cell growth? | CRISPR knockout of SLC16A1 in cancer cell lines |
| Does a specific point mutation in SLC16A2 alter thyroid hormone transport? | Point-mutation knock-in in patient-derived cells |
| Can tagged MCT4 be used to track membrane localization? | Knock-in of fluorescent tag at SLC16A3 locus |
| Does overexpression of MCT1 enhance metabolic coupling? | Overexpression of SLC16A1 in oxidative cells |
| Is dual MCT1/MCT4 inhibition synthetic lethal with metformin? | Double knockout or combinatorial CRISPR in cancer cells |
| Does MCT1/4 mediate itaconate transport in macrophages? | Knockout of SLC16A1 and SLC16A3 in macrophage lines |
How to Study the monocarboxylic acid transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Metabolic flux analysis | Rate of substrate utilization and pathway activity | Cancer metabolism and metabolic coupling |
| Radiolabeled transport assay | Uptake or efflux of monocarboxylic acids | Transporter kinetics and drug interactions |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identifying targets in metabolic pathways |
| Fluorescence imaging | Subcellular localization of transporters | Trafficking and membrane dynamics |
| RNA-seq | Expression levels of SLC16 family genes | Transcriptional regulation and disease profiling |
| Proteomics | Protein abundance and interactions | Identifying accessory proteins like BSG |
| Seahorse extracellular flux | Glycolysis and oxidative phosphorylation | Functional impact of transport inhibition |
| Itaconate transport assay | Macrophage antibacterial activity | Host-pathogen interactions |
Metabolic flux analysis
Metabolic flux analysis using labeled substrates such as 13C-lactate or 13C-pyruvate can measure the rate of monocarboxylic acid transport and its contribution to central carbon metabolism. This approach is useful for studying MCT1 and MCT4 function in cancer and normal cells.
Transport assays with radiolabeled or fluorescent substrates
Direct transport assays using radiolabeled lactate or fluorescent monocarboxylic acid analogs allow quantification of uptake and efflux kinetics. These assays have been used to characterize MCT1 and MCT4 transport activity and to study ferulic acid transport in intestinal models.
CRISPR screening and genetic perturbation
CRISPR knockout and activation screens can identify genes required for monocarboxylic acid transport and its metabolic consequences. Such screens are valuable for uncovering synthetic lethal interactions, as demonstrated for MCT1/MCT4 inhibition with metformin.
Imaging and subcellular localization
Fluorescence imaging of tagged transporters or accessory proteins such as BSG (CD147) can reveal membrane trafficking and localization. This is important for understanding how MCT1 and MCT4 are regulated and how their localization affects transport.
How CRISPR Can Be Used to Study GO:0015718 monocarboxylic acid transport
Knockout
CRISPR knockout of SLC16A1 or SLC16A3 eliminates MCT1 or MCT4 function, allowing researchers to test their requirement for lactate transport, cell growth, and metabolic coupling. Knockout models have been used to demonstrate synthetic lethality with metformin in cancer cells and to study itaconate transport in macrophages.
Point Mutation
Point mutations in SLC16A2 or SLC16A10 can model patient-specific variants that impair thyroid hormone transport. These knock-in models help establish causality between specific residues and transport function, as described in studies of thyroid hormone derivative transporters.
Knock-in
Knock-in of fluorescent or epitope tags at endogenous SLC16A1 or SLC16A3 loci enables real-time tracking of transporter localization and dynamics. This approach is valuable for studying membrane trafficking and interactions with accessory proteins such as BSG.
Overexpression
Overexpression of MCT1 or MCT4 in cell lines can enhance monocarboxylic acid transport and metabolic coupling, providing a gain-of-function system to study downstream effects on metabolism and signaling. This is particularly useful for modeling tumor metabolic symbiosis.
How EDITGENE Supports monocarboxylic acid transport Research
Researchers studying monocarboxylic acid transport-related genes often need to determine whether a candidate gene is causally involved in metabolite flux, metabolic coupling, or disease phenotypes. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for monocarboxylic acid transport research.
Frequently Asked Questions About monocarboxylic acid transport
What is GO:0015718 monocarboxylic acid transport?
GO:0015718 is a Gene Ontology biological process term describing the directed movement of monocarboxylic acids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore.
What genes are involved in monocarboxylic acid transport?
Key genes include SLC16A1 (MCT1), SLC16A3 (MCT4), SLC16A2 (MCT8), and SLC16A10 (MCT10), among others in the SLC16 family.
Which proteins transport lactate across the cell membrane?
MCT1 (SLC16A1) and MCT4 (SLC16A3) are the primary proton-coupled transporters for lactate across the plasma membrane.
How is monocarboxylic acid transport linked to cancer?
Lactate transporters MCT1 and MCT4 support tumor metabolic symbiosis, and their dual inhibition is synthetic lethal with metformin due to NAD+ depletion.
What diseases are associated with monocarboxylic acid transport?
Diseases include cancer, neurodegeneration, thyroid hormone transport disorders, and infectious disease through macrophage itaconate transport.
How can I study monocarboxylic acid transport using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to test the function of transporters like MCT1 and MCT4 in metabolism and disease.
What is the role of MCT1 and MCT4 in metabolism?
MCT1 and MCT4 transport lactate, pyruvate, and ketone bodies, enabling metabolic coupling between cells and supporting energy homeostasis.
Do monocarboxylic acid transporters transport thyroid hormones?
Yes, MCT8 (SLC16A2) and MCT10 (SLC16A10) transport thyroid hormone derivatives, linking GO:0015718 to endocrine regulation.
Can monocarboxylic acid transporters affect drug absorption?
Yes, monocarboxylic acid transporters can mediate transepithelial transport of compounds such as ferulic acid and influence drug interactions.
What methods are used to measure monocarboxylic acid transport?
Methods include radiolabeled transport assays, metabolic flux analysis, CRISPR screening, and fluorescence imaging.
Conclusion
GO:0015718 monocarboxylic acid transport is a fundamental biological process that governs the movement of lactate, pyruvate, ketone bodies, and other monocarboxylic acids across cellular membranes. Its importance spans cancer metabolism, neurodegeneration, endocrine signaling, and immunity, with MCT1 and MCT4 as key molecular players. By leveraging CRISPR knockout, point-mutation, knock-in, and overexpression models, researchers can causally dissect the roles of monocarboxylic acid transporters in health and disease. EDITGENE provides end-to-end services to accelerate this research and translate findings into therapeutic strategies.
References
- 1. Kobayashi M et al.. 2021. Transport function, regulation, and biology of human monocarboxylate transporter 1 (hMCT1) and 4 (hMCT4).. Pharmacol Ther 226:107862 PMID: 33894276
- 2. Lee Y et al.. 2012. Oligodendroglia metabolically support axons and contribute to neurodegeneration.. Nature 487(7408):443-8 PMID: 22801498
- 3. Groeneweg S et al.. 2020. Thyroid Hormone Transporters.. Endocr Rev 41(2) PMID: 31754699
- 4. Chen Z et al.. 2024. 3,3',5-Triiodothyroacetic Acid Transporters.. Thyroid 34(8):1027-1037 PMID: 38836423
- 5. Konishi Y et al.. 2003. Transepithelial transport of ferulic acid by monocarboxylic acid transporter in Caco-2 cell monolayers.. Biosci Biotechnol Biochem 67(4):856-62 PMID: 12784628
- 6. Berginc K et al.. 2010. In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients.. Eur J Nutr 49(6):373-84 PMID: 20140680
- 7. Benjamin D et al.. 2018. Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells.. Cell Rep 25(11):3047-3058.e4 PMID: 30540938
- 8. Meng Q et al.. 2025. Itaconate transport across the plasma membrane and Salmonella-containing vacuole via MCT1/4 modulates macrophage antibacterial activity.. Nat Commun 16(1):10551 PMID: 41298379
